Search Results - Krihova, K

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    HTA166 Cost-Effectiveness of Combination Pertuzumab+Trastuzumab Vs Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer (HER2+ eBC) in the Czech Republic

    HTA166 Cost-Effectiveness of Combination Pertuzumab+Trastuzumab Vs Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer (HER2+ eBC) in the Czech Rep... by Motylova, S., Dolezel, J., Novák, J., Pour, M., Krihova, K., Skalicky, D.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    HTA80 Cost-Effectiveness of Ocrelizumab Compared with Dmt for the Treatment of Relapsing-Remitting Multiple Sclerosis in Czech Republic

    HTA80 Cost-Effectiveness of Ocrelizumab Compared with Dmt for the Treatment of Relapsing-Remitting Multiple Sclerosis in Czech Republic by Pour, M., J, Novák, Motylova, S., Skalicky, D., Krihova, K., Dolezel, J.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    HTA73 Cured and Invisible? Rationale for Mixture-Cure Models As Base-Case for HTA in Diffuse-Large B-Cell Lymphoma (DLBCL)

    HTA73 Cured and Invisible? Rationale for Mixture-Cure Models As Base-Case for HTA in Diffuse-Large B-Cell Lymphoma (DLBCL) by Novák, J, Vodicka, P, Janikova, A, Belada, D, Motylova, S, Pour, M, Dolezel, J, Krihova, K, Muzik, J, Skalicky, D, Trneny, M

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: